Nature (2013)
Common adverse reactions (incidence 5%) in adults or pediatric patients aged 12 years and older include nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, dyspepsia, dizziness, abdominal distension, eructation, hypoglycemia in patients with type 2 diabetes, flatulence, gastroenteritis, gastroesophageal reflux disease, and nasopharyngitis
In SUSTAIN 6, the cardiovascular outcome trial, 788 (48.0%) OZEMPIC-treated patients were 65 years of age and over and 157 OZEMPIC-treated patients (9.6%) patients were 75 years of age and over
Frequently asked questions What is the best Retatrutide Mixing - Premium Retatrutide Peptide Dosing 2026
[47] Side effects [edit] The most commonly reported adverse effects for I } : CS1 maint: bot: original URL status unknown (link) "Acetylcysteine Oral Inhalation: MedlinePlus Drug Information"